Abstract
The dopamine (DA) hypothesis of schizophrenia, which was based largely on evidence that pharmacological manipulations of DA systems influence the symptoms of schizophrenia, is undergoing a transformation due to our knowledge of the anatomy and pharmacology of additional subtypes of dopamine receptors. New research links the multiplicity of D2-like receptors to divergent neuroanatomic sites of suspected pathology in schizophrenia. We hypothesize that this research suggests that D2 receptors in the basal ganglia are the likely site of extrapyramidal symptoms and not antipsychotic effects. Rather, D3 receptors of the mesolimbic system are a likely site of antipsychotic effects, and D2 and D4 receptors in the medial temporal lobe and limbic cortical areas are the sites of additional antipsychotic effects. This work also suggests that divergent DA receptor circuits are likely associated with the pathophysiology of this disorder.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Joyce, J., Meador-Woodruff, J. Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia. Neuropsychopharmacol 16, 375–384 (1997). https://doi.org/10.1016/S0893-133X(96)00276-X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S0893-133X(96)00276-X
Keywords
This article is cited by
-
Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia
Neuropsychopharmacology (2020)
-
Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
Neuropsychopharmacology (2014)
-
Gene-Environment Contributions to Young Adult Sexual Partnering
Archives of Sexual Behavior (2007)
-
Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride
Psychopharmacology (2005)